PDS Biotechnology Corp Amortization of Debt Discount (Premium)
PDS Biotechnology Corp (PDSB) reported Amortization of Debt Discount (Premium) of $714.39 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow › Operating Activities
us-gaap:AmortizationOfDebtDiscountPremium · last filed 2026-08-13
- PDS Biotechnology Corp amortization of debt discount (premium) for the quarter ending 2026-06-30 was $265.55K, a 76.16% decline year-over-year.
- PDS Biotechnology Corp amortization of debt discount (premium) for the quarter ending 2026-03-31 was $448.84K, a 64.66% increase year-over-year.
- PDS Biotechnology Corp amortization of debt discount (premium) for the quarter ending 2025-12-31 was $474.41K, a 59.32% increase year-over-year.
- PDS Biotechnology Corp amortization of debt discount (premium) for the quarter ending 2025-09-30 was -$307.18K, a 200.67% decline year-over-year.
- PDS Biotechnology Corp amortization of debt discount (premium) for fiscal 2025 was $1.55M, a 34.31% increase from fiscal 2024.
- PDS Biotechnology Corp amortization of debt discount (premium) for fiscal 2024 was $1.16M, a 77.44% increase from fiscal 2023.
- PDS Biotechnology Corp amortization of debt discount (premium) for fiscal 2023 was $652.01K, a 254.52% increase from fiscal 2022.
- PDS Biotechnology Corp amortization of debt discount (premium) for fiscal 2022 was $183.91K.
| Period end | Amortization of Debt Discount (Premium) 3 month | Amortization of Debt Discount (Premium) 6 month | Amortization of Debt Discount (Premium) 9 month | Amortization of Debt Discount (Premium) 12 month |
|---|---|---|---|---|
| 2026-06-30 | $265.55K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | $714.39K 10-Q · filed 2026-08-13 | $1.19M derived: sum of 3 quarters · filed 2026-08-13 | $881.62K derived: sum of 4 quarters · filed 2026-08-13 |
| 2026-03-31 | $448.84K 10-Q · filed 2026-05-14 | $923.25K derived: sum of 2 quarters · filed 2026-05-14 | $616.07K derived: sum of 3 quarters · filed 2026-05-14 | $1.73M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-12-31 | $474.41K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | $167.23K derived: sum of 2 quarters · filed 2026-03-30 | $1.28M derived: sum of 3 quarters · filed 2026-08-13 | $1.55M 10-K · filed 2026-03-30 |
| 2025-09-30 | -$307.18K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $806.85K derived: sum of 2 quarters · filed 2026-08-13 | $1.08M 10-Q · filed 2025-11-13 | $1.38M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-06-30 | $1.11M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | $1.39M 10-Q · filed 2026-08-13 | $1.68M derived: sum of 3 quarters · filed 2026-08-13 | $1.99M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-03-31 | $272.58K 10-Q · filed 2026-05-14 | $570.35K derived: sum of 2 quarters · filed 2026-05-14 | $875.47K derived: sum of 3 quarters · filed 2026-05-14 | $1.16M derived: sum of 4 quarters · filed 2026-05-14 |
| 2024-12-31 | $297.77K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | $602.89K derived: sum of 2 quarters · filed 2026-03-30 | $886.67K derived: sum of 3 quarters · filed 2026-03-30 | $1.16M 10-K · filed 2026-03-30 |
| 2024-09-30 | $305.13K 10-Q · filed 2024-11-14 | $588.90K derived: sum of 2 quarters · filed 2024-11-14 | $859.13K 10-Q · filed 2025-11-13 | $1.12M derived: sum of 4 quarters · filed 2025-05-14 |
| 2024-06-30 | $283.77K 10-Q · filed 2024-08-13 | $554.01K 10-Q · filed 2025-08-13 | $814.10K derived: sum of 3 quarters · filed 2025-05-14 | $972.49K derived: sum of 4 quarters · filed 2025-05-14 |
| 2024-03-31 | $270.24K 10-Q · filed 2025-05-14 | $530.32K derived: sum of 2 quarters · filed 2025-05-14 | $688.72K derived: sum of 3 quarters · filed 2025-05-14 | $810.72K derived: sum of 4 quarters · filed 2025-05-14 |
| 2023-12-31 | $260.09K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-27 | $418.48K derived: sum of 2 quarters · filed 2025-03-27 | $540.48K derived: sum of 3 quarters · filed 2025-03-27 | $652.01K 10-K · filed 2025-03-27 |
| 2023-09-30 | $158.40K 10-Q · filed 2024-11-14 | $280.39K derived: sum of 2 quarters · filed 2024-11-14 | $391.92K 10-Q · filed 2024-11-14 | $513.58K derived: sum of 4 quarters · filed 2024-11-14 |
| 2023-06-30 | $122.00K 10-Q · filed 2024-08-13 | $233.52K 10-Q · filed 2024-08-13 | $355.19K derived: sum of 3 quarters · filed 2024-08-13 | $427.91K derived: sum of 4 quarters · filed 2024-08-13 |
| 2023-03-31 | $122.00K 10-Q · filed 2024-05-15 | $233.19K derived: sum of 2 quarters · filed 2024-05-15 | $305.91K derived: sum of 3 quarters · filed 2024-05-15 | $305.91K derived: sum of 4 quarters · filed 2024-05-15 |
| 2022-12-31 | $111.19K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | $183.91K derived: sum of 2 quarters · filed 2024-03-28 | $183.91K derived: sum of 3 quarters · filed 2024-03-28 | $183.91K 10-K · filed 2024-03-28 |
| 2022-09-30 | $72.72K 10-Q · filed 2022-11-14 | $72.72K derived: sum of 2 quarters · filed 2023-08-14 | $72.72K 10-Q · filed 2023-11-14 | $72.72K derived: sum of 4 quarters · filed 2023-08-14 |
| 2022-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | $0.00 10-Q · filed 2023-08-14 | $0.00 derived: sum of 3 quarters · filed 2023-08-14 | |
| 2022-03-31 | $0.00 10-Q · filed 2023-05-15 | $0.00 derived: sum of 2 quarters · filed 2023-05-15 | ||
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-28 | $0.00 10-K · filed 2023-03-28 | ||
| 2021-09-30 | $0.00 10-Q · filed 2022-11-14 | |||
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-21 | $0.00 derived: sum of 2 quarters · filed 2019-02-21 | $0.00 derived: sum of 3 quarters · filed 2019-02-21 | $1.04K 10-K · filed 2019-02-21 |
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-01 | $0.00 derived: sum of 2 quarters · filed 2018-11-01 | $1.04K 10-Q · filed 2018-11-01 | $5.04K derived: sum of 4 quarters · filed 2019-02-21 |
| 2018-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-01 | $1.04K 10-Q · filed 2018-08-01 | $5.04K derived: sum of 3 quarters · filed 2019-02-21 | $11.90K derived: sum of 4 quarters · filed 2019-02-21 |
| 2018-03-31 | $1.04K 10-Q · filed 2018-05-01 | $5.04K derived: sum of 2 quarters · filed 2019-02-21 | $11.90K derived: sum of 3 quarters · filed 2019-02-21 | $21.54K derived: sum of 4 quarters · filed 2019-02-21 |
| 2017-12-31 | $4.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-21 | $10.86K derived: sum of 2 quarters · filed 2019-02-21 | $20.50K derived: sum of 3 quarters · filed 2019-02-21 | $32.87K 10-K · filed 2019-02-21 |
| 2017-09-30 | $6.86K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-01 | $16.51K derived: sum of 2 quarters · filed 2018-11-01 | $28.87K 10-Q · filed 2018-11-01 | $43.88K derived: sum of 4 quarters · filed 2018-11-01 |
| 2017-06-30 | $9.65K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-01 | $22.01K 10-Q · filed 2018-08-01 | $37.02K derived: sum of 3 quarters · filed 2018-08-01 | $54.60K derived: sum of 4 quarters · filed 2018-08-01 |
| 2017-03-31 | $12.37K 10-Q · filed 2018-05-01 | $27.37K derived: sum of 2 quarters · filed 2018-05-01 | $44.96K derived: sum of 3 quarters · filed 2018-05-01 | $65.05K derived: sum of 4 quarters · filed 2018-05-01 |
| 2016-12-31 | $15.01K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-01 | $32.59K derived: sum of 2 quarters · filed 2018-03-01 | $52.68K derived: sum of 3 quarters · filed 2018-03-01 | $75.21K 10-K · filed 2018-03-01 |
| 2016-09-30 | $17.58K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-01 | $37.67K derived: sum of 2 quarters · filed 2017-11-01 | $60.21K 10-Q · filed 2017-11-01 | $85.12K derived: sum of 4 quarters · filed 2018-03-01 |
| 2016-06-30 | $20.09K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-01 | $42.62K 10-Q · filed 2017-08-01 | $67.53K derived: sum of 3 quarters · filed 2018-03-01 | $94.00K derived: sum of 4 quarters · filed 2018-03-01 |
| 2016-03-31 | $22.53K 10-Q · filed 2017-05-03 | $47.45K derived: sum of 2 quarters · filed 2018-03-01 | $73.91K derived: sum of 3 quarters · filed 2018-03-01 | $100.38K derived: sum of 4 quarters · filed 2018-03-01 |
| 2015-12-31 | $24.91K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-01 | $51.38K derived: sum of 2 quarters · filed 2018-03-01 | $77.84K derived: sum of 3 quarters · filed 2018-03-01 | $104.31K 10-K · filed 2018-03-01 |
| 2015-09-30 | $26.47K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-01 | $52.93K derived: sum of 2 quarters · filed 2016-11-01 | $79.40K 10-Q · filed 2016-11-01 | $105.87K derived: sum of 4 quarters · filed 2017-03-02 |
| 2015-06-30 | $26.47K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-03 | $52.93K 10-Q · filed 2016-08-03 | $79.40K derived: sum of 3 quarters · filed 2017-03-02 | |
| 2015-03-31 | $26.47K 10-Q · filed 2016-05-03 | $52.93K derived: sum of 2 quarters · filed 2017-03-02 | ||
| 2014-12-31 | $26.47K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-02 | $35.29K 10-K · filed 2017-03-02 | ||
| 2014-09-30 | $8.82K 10-Q · filed 2015-11-06 | |||
| 2013-12-31 | $0.00 10-K · filed 2016-03-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| VERU INC. (VERU) | United States | $0.043B | -3.93 |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B | |
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| Lite Strategy, Inc. (LITS) | United States | $0.049B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |